References
- Varghese L, Mungall B, Zhang XH, et al. Response to Wu et al. — cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother. 2016;12(10):2675–2680.
- Wu DB, Roberts C, Lee VW, et al. Cost-effectiveness analysis of infant universal routine pneumococcal vaccination in Malaysia and Hong Kong. Hum Vaccin Immunother. 2016;12(2):403–416. PubMed PMID: 26451658; PubMed Central PMCID: PMCPMC5049716.
- Wasserman M, Sings HL, Jones D, et al. Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine. Expert Rev Vaccines. 2018 Jan;17(1):71–78. PubMed PMID: 29164952.
- Dominguez A, Ciruela P, Hernandez S, et al. Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study. PloS One. 2017;12(8):e0183191. PubMed PMID: 28806737; PubMed Central PMCID: PMCPMC5555701.
- Moore MR, Link-Gelles R, Schaffner W, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study. Lancet Respir Med. 2016 May;4(5):399–406. PubMed PMID: 26987984.
- Weinberger R, van der Linden M, Imohl M, et al. Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule. Vaccine. 2016 Apr 19;34(18):2062–2065. PubMed PMID: 26920471.
- van der Linden M, Falkenhorst G, Perniciaro S, et al. Effectiveness of pneumococcal conjugate vaccines (PCV7 and PCV13) against invasive pneumococcal disease among children under two years of age in Germany. PloS One. 2016;11(8):e0161257. PubMed PMID: 27526117; PubMed Central PMCID: PMCPMC4985133.
- Andrews NJ, Waight PA, Burbidge P, et al. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis. 2014 Sep;14(9):839–846. PubMed PMID: 25042756.
- Miller E, Andrews NJ, Waight PA, et al. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine. 2011 Nov 15;29(49):9127–9131. PubMed PMID: 21983361.
- Savulescu C, Hanqeut G. PCV13 effectiveness and overall effect of PCV10/13 vaccination programmes in children under five years of age. SpIDnet multicentre studies. ESCAIDE November 2016. 2016; Available from: https://www.slideshare.net/ECDC_EU/camelia-savulescu-pcv13-effectiveness-and-overall-effect-of-pcv1013-vaccination-programmes-in-children-under-five-years-of-age-spidnet-multicentre-studies?qid=c8833740-53d0-4c03-8163-533f54e86d29&v=&b=&from_search=2.
- Savulescu C, Krizova P, Lepoutre A, et al. Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study. Lancet Respir Med. 2017 Aug;5(8):648–656. PubMed PMID: 28359798.
- Hanquet G, Savulescu C. Indirect effect of infant PCV10/13 vaccination on IPD in the elderly: polled analysis from 13 EU sites. 2016. [cited 2018 May 21]; Available from: https://www.slideshare.net/ECDC_EU/germaine-hanquet-indirect-effect-of-infant-pcv1013-vaccination-on-ipd-in-the-elderly-pooled-analysis-from-13-eu-sites.
- Rinta-Kokko H, Palmu AA, Auranen K, et al. Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland. Vaccine. 2018 Apr 5;36(15):1934–1940. PubMed PMID: 29526371.
- Brandileone MC, Almeida SCG, Minamisava R, et al. Distribution of invasive Streptococcus pneumoniae serotypes before and 5years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil. Vaccine. 2018 May 3;36(19):2559–2566. PubMed PMID: 29650385.
- Vissers M, Wijmenga-Monsuur AJ, Knol MJ, et al. Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands. PloS One. 2018;13(3):e0194823. PubMed PMID: 29601605; PubMed Central PMCID: PMCPMC5877862.
- National Reference Laboratory for Pneumococci. Surveillance van de pneumokokkeninfecties in België. Verslag voor 2017. 2017 [cited 2018 May 05]; Available from: https://nrchm.wiv-isp.be/nl/ref_centra_labo/streptococcus_pneumoniae_invasive/Rapporten/Streptococcus%20pneumoniae%202017.pdf.